Sweden Urges WHO to Focus on Smokeless Alternatives

Oct.23.2023
Sweden Urges WHO to Focus on Smokeless Alternatives
Swedish tobacco research institute urges WHO to focus on Sweden's success in reducing smoking-related deaths with smoke-free alternatives.

In recent news, a recent research paper published by the Institute of Tobacco Studies in Sweden (ITS) has urged the World Health Organization (WHO) to take note of Sweden's successful large-scale transition to smokeless alternative products in order to reduce global smoking-related deaths.


According to the paper, the best example comes from Sweden, where the male smoking rate is the lowest in the European Union, hence resulting in the lowest tobacco-related mortality rate.


The Swedish Tobacco Research Institute (ITS) recently published a paper highlighting its successful experiences in reducing global smoking-related mortality rates. The paper calls on the World Health Organization (WHO) to shift its focus towards smokeless alternatives. This paper has been published on Qeios and is available for download.


The principal investigator of this study is Dr. Lars M. Ramström, who has previously served as an expert for the World Health Organization and as the Secretary-General of international conferences on smoking and health issues.


According to the paper, "The WHO needs to employ all evidence-based strategies to reduce tobacco-related mortality." The paper also emphasizes that harm reduction is one of the three pillars of tobacco control measures and without it, the measures advocated by the WHO to reduce demand and supply will be ineffective.


In addition, this study also brings to the attention of the World Health Organization the experiences of countries like Sweden, Norway, Japan, and New Zealand. The study emphasizes that in Japan, a significant number of smokers have shifted towards heated tobacco products, resulting in a decline in smoking rates from approximately 20% in 2014 to 13% in 2019.


The paper ultimately urges the World Health Organization to base their tobacco policies on scientific evidence and to follow the example of Sweden.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Nicoventures Granted Rehearing After Philip Morris Challenge Rejected
Nicoventures Granted Rehearing After Philip Morris Challenge Rejected
Nicoventures Trading Ltd., a subsidiary of British American Tobacco (BAT), has won an appeal at the European Patent Office (EPO), convincing the appellate board that examiners had violated its right to be heard by failing to review all of its submissions.
Dec.09 by 2FIRSTS.ai
EU to Abstain from WHO Tobacco Treaty Vote Amid Deep Internal Split
EU to Abstain from WHO Tobacco Treaty Vote Amid Deep Internal Split
The European Union will abstain from voting at the upcoming 11th session of the WHO Framework Convention on Tobacco Control (COP11) in Geneva, following months of internal disagreement over how to regulate tobacco and nicotine products. The decision marks a rare and public fracture in EU health policy, reportedly driven by the European Commission’s hardline anti-tobacco stance.
Nov.18 by 2FIRSTS.ai
Product | FASTA Unveils New U.S. Offering, Citing “Made in USA” Status and Texas Compliance
Product | FASTA Unveils New U.S. Offering, Citing “Made in USA” Status and Texas Compliance
FASTA has launched a new disposable, the FASTA ALIEN 51K, on U.S. online channels. Retailer Mi-Pod describes the product as “assembled and filled in the U.S.” and labels it as compliant with Texas e-cigarette registration requirements. The ALIEN 51K is now available via Mi-Pod and Vaping, with a suggested retail price of about $19.99.
Nov.12 by 2FIRSTS.ai
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
President Donald Trump signed the Continuing Appropriations Act, 2026 (H.R.5371) on November 12, Section 772 of Part B—the Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act (S.2256)—requires the FDA to allocate no less than $200 million in tobacco user fees to enforce regulations against illegal e-cigarettes, vapes, and other ENDS products. At least $2 million of this funding supports a federal multi-agency task force targeting products originating from the China.
Nov.14 by 2FIRSTS.ai
Philip Morris and R.J. Reynolds Face Trial Over Woman’s Lung Cancer Death in Massachusetts
Philip Morris and R.J. Reynolds Face Trial Over Woman’s Lung Cancer Death in Massachusetts
According to Law360, the family of Maria Petruzziello has taken Philip Morris and R.J. Reynolds to trial in Massachusetts, alleging the companies are responsible for her 2019 lung cancer death after decades of smoking. Plaintiffs argue her experience mirrors many smokers, while the defense points to her years-long cessation and personal choice.
Dec.03 by 2FIRSTS.ai
2Firsts Exclusive | AVM President Allison Boughner: The U.S. Vape Market Reshapes Under a Regulatory Storm
2Firsts Exclusive | AVM President Allison Boughner: The U.S. Vape Market Reshapes Under a Regulatory Storm
Amid intensified regulation and sweeping market shifts, the U.S. vaping industry is undergoing a profound transformation. In an exclusive interview with 2Firsts, AVM President Allison Boughner discusses how enforcement is reshaping brands, distribution, products, compliance, and U.S.-based manufacturing.
Oct.20